Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCGN

Ocugen Inc

Apr 30 • 11:01AM ET

1.75

+0.07 3.87 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: PFE MRNA BNTX NVAX INO VXRT SAGE MCRB ADMA VTVT

| Held by: VTI XBI VXF KOMP VHT ITOT IDNA LABU MOON ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.23	Insider Own	2.80%	Shs Outstand	312.38M	Perf Week	4.49%
Market Cap	590.71M	Forward P/E	30.79	EPS next Y	0.06	Insider Trans	0.00%	Shs Float	-	Perf Month	-3.59%
Enterprise Value	605.28M	PEG	-	EPS next Q	-0.05	Inst Own	22.26%	Short Float	-	Perf Quarter	14.80%
Income	-67.85M	P/S	133.95	EPS this Y	5.59%	Inst Trans	4.83%	Short Ratio	8.72	Perf Half Y	14.80%
Sales	4.41M	P/B	-	EPS next Y	126.10%	ROA	-106.32%	Short Interest	67.89M	Perf YTD	29.26%
Book/sh	-0.04	P/C	31.81	EPS next 5Y	-	ROE	-776.89%	52W High	2.72 -35.96%	Perf Year	133.54%
Cash/sh	0.05	P/FCF	-	EPS past 3/5Y	17.64% 5.89%	ROIC	-359.54%	52W Low	0.64 172.66%	Perf 3Y	144.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	21.05% 152.94%	Gross Margin	45.00%	Volatility	5.50% 6.20%	Perf 5Y	-86.23%
Dividend TTM	-	EV/Sales	137.25	EPS Y/Y TTM	-24.90%	Oper. Margin	-1425.70%	ATR (14)	0.13	Perf 10Y	-98.72%
Dividend Ex-Date	-	Quick Ratio	1.06	Sales Y/Y TTM	8.83%	Profit Margin	-1537.41%	RSI (14)	46.76	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.06	EPS Q/Q	-18.87%	SMA20	-2.14%	Beta	2.33	Target Price	11.57
Payout	-	Debt/Eq	-	Sales Q/Q	-125.26%	SMA50	-7.17%	Rel Volume	0.52	Prev Close	1.68
Employees	116	LT Debt/Eq	-	Earnings	May 05 BMO	SMA200	18.49%	Avg Volume	7.79M	Price	1.75
IPO	Dec 03, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.04% -117.95%	Trades		Volume	1,099,382	Change	3.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)